National Bank Of Canada Bria Cell Therapeutics Corp. Transaction History

National Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	BUY	$4.28 - $6.03 $10,700 - $15,075	2,500 New	2,500 $0
Q2 2022 Jul 28, 2022	SELL	$4.28 - $11.9 $595,348 - $1.66 Million	-139,100 Reduced 88.66%	17,800 $103,000
Q1 2022 May 05, 2022	BUY	$5.91 - $10.14 $750,570 - $1.29 Million	127,000 Added 424.75%	156,900 $1.59 Million
Q4 2021 Jan 24, 2022	BUY	$7.1 - $10.61 $212,290 - $317,239	29,900 New	29,900 $248,000

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $16M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.